Long non coding RNA MALAT1 promotes tumor growth and metastasis by inducing epithelial-mesenchymal transition in oral squamous cell carcinoma

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Zhou, Xuan ^a   Liu, Su ^a   Cai, Guoshuai ^b   Kong, Lingping ^a   Zhang, Tingting ^a   Ren, Yu ^a   Wu, Yansheng ^a   Mei, Mei ^a   Zhang, Lun ^a   Wang, Xudong ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LONG UNTRANSLATED RNA; MALAT1 LONG NON-CODING RNA, HUMAN;

ANIMAL; CELL MOTION; CELL PROLIFERATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METASTASIS; MOUSE; MOUTH TUMOR; NUDE MOUSE; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

ANIMALS; BETA CATENIN; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, NUDE; MOUTH NEOPLASMS; NEOPLASM METASTASIS; NF-KAPPA B; PROGNOSIS; RNA, LONG NONCODING;

EID: 84946565784     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep15972     Document Type: Article

References (42)

1. Warnakulasuriya, S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 45, 309-316 (2009).
2. Leemans, C. R. , Braakhuis, B. J. & Brakenhoff, R. H. The molecular biology of head and neck cancer. Nat Rev Cancer 11, 9-22 (2011).
3. Acloque, H. et al. Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. J Clin Invest 119, 1438-1449 (2009).
4. Polyak, K. & Weinberg, R. A. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 9, 265-273 (2009).
5. Wang, Y. et al. Akt/Ezrin Tyr353/NF-kappaB pathway regulates EGF-induced EMT and metastasis in tongue squamous cell carcinoma. Br J Cancer 110, 695-705 (2014).
6. Konigshoff, M. et al. WNT1-inducible signaling protein-1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis. J Clin Invest 119, 772-787 (2009).
7. Salt, M. B. , Bandyopadhyay, S. & McCormick, F. Epithelial-to-mesenchymal transition rewires the molecular path to PI3Kdependent proliferation. Cancer Discov 4, 186-199 (2014).
8. Zhang, K. L. et al. Blockage of a miR-21/EGFR regulatory feedback loop augments anti-EGFR therapy in glioblastomas. Cancer Lett 342, 139-149 (2014).
9. Gutschner, T. & Diederichs, S. The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol 9, 703-719 (2012).
10. Tano, K. & Akimitsu, N. Long non-coding RNAs in cancer progression. Front Genet 3, 219 (2012).
11. Eissmann, M. et al. Loss of the abundant nuclear non-coding RNA MALAT1 is compatible with life and development. RNA Biol 9, 1076-1087 (2012).
12. Ji, P. et al. MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 22, 8031-8041 (2003).
13. Hu, L. et al. Up-regulation of long noncoding RNA MALAT1 contributes to proliferation and metastasis in esophageal squamous cell carcinoma. J Exp Clin Cancer Res 34, 7 (2015).
14. Ma, K. X. et al. Long noncoding RNA MALAT1 associates with the malignant status and poor prognosis in glioma. Tumour Biol 36, 3355-3359 (2015).
15. Hirata, H. et al. Long Noncoding RNA MALAT1 Promotes Aggressive Renal Cell Carcinoma through Ezh2 and Interacts with miR-205. Cancer research 75, 1322-1331 (2015).
16. Li, S. et al. Sp1-mediated transcriptional regulation of MALAT1 plays a critical role in tumor. J Cancer Res Clin Oncol 141, 1909-20 (2015).
17. Wang, X. et al. Silencing of long noncoding RNA MALAT1 by miR-101 and miR-217 inhibits proliferation, migration, and invasion of esophageal squamous cell carcinoma cells. J Biol Chem 290, 3925-3935 (2015).
18. Schmidt, L. H. et al. The long noncoding MALAT-1 RNA indicates a poor prognosis in non-small cell lung cancer and induces migration and tumor growth. J Thorac Oncol 6, 1984-1992 (2011).
19. Gutschner, T. et al. The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer research 73, 1180-1189 (2013).
20. Lunardi, S. , Muschel, R. J. & Brunner, T. B. The stromal compartments in pancreatic cancer: are there any therapeutic targets? Cancer Lett 343, 147-155 (2014).
21. Bourboulia, D. & Stetler-Stevenson, W. G. Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion. Semin Cancer Biol 20, 161-168 (2010).
22. Vergara, D. et al. Epithelial-mesenchymal transition in ovarian cancer. Cancer Lett 291, 59-66 (2010).
23. Eckert, M. A. & Yang, J. Targeting invadopodia to block breast cancer metastasis. Oncotarget 2, 562-568 (2011).
24. Tsai, M. C. et al. Long noncoding RNA as modular scaffold of histone modification complexes. Science 329, 689-693 (2010).
25. Gupta, R. A. et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464, 1071-1076 (2010).
26. Zhang, K. et al. Long non-coding RNA HOTAIR promotes glioblastoma cell cycle progression in an EZH2 dependent manner. Oncotarget 6, 537-546 (2015).
27. Sorensen, K. P. et al. Long non-coding RNA HOTAIR is an independent prognostic marker of metastasis in estrogen receptorpositive primary breast cancer. Breast cancer research and treatment 142, 529-536 (2013).
28. Cai, B. , Song, X. Q. , Cai, J. P. & Zhang, S. HOTAIR: a cancer-related long non-coding RNA. Neoplasma 61, 379-391 (2014).
29. Park, J. Y. et al. Roles of Long Non-Coding RNAs on Tumorigenesis and Glioma Development. Brain Tumor Res Treat 2, 1-6 (2014).
30. Zhao, Z. , Chen, C. , Liu, Y. & Wu, C. 17beta-Estradiol treatment inhibits breast cell proliferation, migration and invasion by decreasing MALAT-1 RNA level. Biochem Biophys Res Commun 445, 388-393 (2014).
31. Wang, F. et al. Development and prospective multicenter evaluation of the long noncoding RNA MALAT-1 as a diagnostic urinary biomarker for prostate cancer. Oncotarget 5, 11091-11102 (2014).
32. Tang, H. , Wu, Z. , Zhang, J. & Su, B. Salivary lncRNA as a potential marker for oral squamous cell carcinoma diagnosis. Mol Med Rep 7, 761-766 (2013).
33. Zhang, J. , Zhang, B. , Wang, T. & Wang, H. LncRNA MALAT1 overexpression is an unfavorable prognostic factor in human cancer: evidence from a meta-analysis. Int J Clin Exp Med 8, 5499-5505 (2015).
34. Ji, Q. et al. Long non-coding RNA MALAT1 promotes tumour growth and metastasis in colorectal cancer through binding to SFPQ and releasing oncogene PTBP2 from SFPQ/PTBP2 complex. Br J Cancer 111, 736-748 (2014).
35. Shen, L. et al. Long noncoding RNA MALAT1 promotes brain metastasis by inducing epithelial-mesenchymal transition in lung cancer. J Neurooncol 121, 101-108 (2015).
36. Wu, X. S. et al. MALAT1 promotes the proliferation and metastasis of gallbladder cancer cells by activating the ERK/MAPK pathway. Cancer Biol Ther 15, 806-814 (2014).
37. Chen, H. et al. Cisplatin and paclitaxel target significant long noncoding RNAs in laryngeal squamous cell carcinoma. Med Oncol 31, 246 (2014).
38. Chua, H. L. et al. NF-kappaB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2. Oncogene 26, 711-724 (2007).
39. Jamieson, C. , Sharma, M. & Henderson, B. R. Wnt signaling from membrane to nucleus: beta-catenin caught in a loop. Int J Biochem Cell Biol 44, 847-850 (2012).
40. Tripathi, V. et al. Long noncoding RNA MALAT1 controls cell cycle progression by regulating the expression of oncogenic transcription factor B-MYB. PLoS Genet 9, e1003368 (2013).
41. Ren, S. et al. Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 derived miniRNA as a novel plasma-based biomarker for diagnosing prostate cancer. Eur J Cancer 49, 2949-2959 (2013).
42. Zhou, X. et al. Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status. Lab Invest 90, 144-155 (2010).